ROS Activated NETosis of Bone Marrow CD55 + Intermediate Mature Neutrophils Through HIF1α‐PADI4 Pathway to Initiate Bone Aging

Read full text
Authors: Yutong Guo, Shengjie Cui, Wen Xi, Yidi Wang, Yidi Wang, Ben Wu, Yixiang Wang, Yixiang Wang, Yan Gu
Cited by: 4
References: 38

Abstract

ABSTRACT Neutrophil NETosis is markedly dysregulated in the aging body. Bone marrow serves as the powerhouse of neutrophil differentiation, while the state of neutrophil NETosis therein and its relationship with bone aging remains largely elusive. Moreover, it remains unclear how neutrophil heterogeneity and pro‐inflammatory cues within bone marrow synergistically regulate neutrophil NETosis. Here, we find neutrophil NETosis is highly activated in the bone marrow of 3‐mon male senescence‐accelerated mouse prone 6 (SAMP6), and the released NETs induce BMSCs senescence and impairs their osteogenesis. Further, we verify in vivo NETs‐clearance significantly ameliorates bone aging of 3‐mon male SAMP6 mice. Next, through scRNA‐seq we find a CD55 + intermediate mature neutrophil subset enriching in the 3‐mon male SAMP6 bone marrow, characterized by significantly upregulated NETosis. Through cell transfer, we demonstrate this subset directly induces bone aging. Mechanistically, elevated ROS within the bone marrow of SAMP6 integrates with a CD55‐primed HIF1ɑ‐PADI4 pathway to trigger NETosis, and senescent BMSCs serve as a ROS‐producer. In summary, our results demonstrate that activated NETosis in CD55 + intermediate‐mature neutrophils plays a key role in initiating bone aging. Also, we uncover the vicious cycle of inflammaging between immune dysregulation and cellular senescence in bone marrow, providing potential targets for osteoporosis treatment.

Fields of Study & Subjects

Neutrophil Myeloperoxidase and Oxidative Mechanisms Immune cells in cancer Blood disorders and treatments

Publication details

Journal / source
Advanced Science
Publisher
Wiley
Volume
13
Issue
16
Pages
e00046–e00046
Publication date
8 January 2026
Language
EN